Edition:
India

Greenhill & Co Inc (GHL.N)

GHL.N on New York Stock Exchange

20.05USD
16 Feb 2018
Change (% chg)

$-0.35 (-1.72%)
Prev Close
$20.40
Open
$20.35
Day's High
$20.45
Day's Low
$20.00
Volume
85,197
Avg. Vol
149,765
52-wk High
$31.35
52-wk Low
$13.80

Chart for

About

Greenhill & Co., Inc. is an investment bank. The Company provides financial and strategic advice on domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising and other transactions to a diverse client base, including corporations, partnerships, institutions and governments... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $497.93
Shares Outstanding(Mil.): 29.64
Dividend: 0.45
Yield (%): 10.71

Financials

BRIEF-Greenhill Announces Terms For Modified Dutch Auction Tender Offer

* GREENHILL ANNOUNCES TERMS FOR MODIFIED DUTCH AUCTION TENDER OFFER

13 Feb 2018

BRIEF-Greenhill & Co Reports Q4 Loss Per Share $0.85 Including Items

* GREENHILL & CO. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

07 Feb 2018

BRIEF-Scott Bok Reports 5 Percent Stake In Greenhill & Co

* SCOTT BOK REPORTS 5 PERCENT STAKE IN GREENHILL & CO INC AS ON JANUARY 10 - SEC FILING Source text: (http://bit.ly/2CYcCTS) Further company coverage:

10 Jan 2018

BRIEF-HSBC Has Appointed Anthony Parsons As Vice-Chairman, Global Banking From Greenhill

* HAS APPOINTED ANTHONY PARSONS AS VICE-CHAIRMAN, GLOBAL BANKING FROM GREENHILL Source text for Eikon: Further company coverage:

18 Dec 2017

BRIEF-Greenhill & Co reports third quarter loss per share of $0.18

* Greenhill & Co Inc reports third quarter loss per share of $0.18

19 Oct 2017

BRIEF-Greenhill & Co enters credit agreement

* Greenhill & Co Inc - ‍on October 12, co entered credit agreement - sec filing​

13 Oct 2017

BRIEF-GREENHILL ANNOUNCES INCREASE IN PLANNED SHARE REPURCHASE TO $285 MLN

* GREENHILL ANNOUNCES REVISED TERMS FOR RECAPITALIZATION AND SHARE REPURCHASE

09 Oct 2017

BRIEF-Greenhill announces plan for recapitalization and major share repurchase

* Greenhill announces plan for recapitalization and major share repurchase

26 Sep 2017

BRIEF-Mabvax Therapeutics engages Greenhill & co. as advisor for exploring strategic alternatives

* Mabvax Therapeutics engages Greenhill & Co. as advisor for exploring strategic alternatives

06 Sep 2017

Earnings vs. Estimates